Pulling SEC filings + quote and writing the call…

OLAPLEX HOLDINGS, INC.
Next earnings Aug 5, 2026 (before open) · consensus $0.02 EPS, $110M rev
Last earnings -0.2% on 2026-05-11
Fallen beauty brand: revenue finally flat and balance sheet deleveraged, but profits collapsed into a loss on an unproven turnaround — own, don't add.
Revenue (FY2025) $423M · FY2025
Olaplex is a high-gross-margin (69.4%) prestige hair-care brand mid-way through a self-described 'business transformation plan' and an international distribution 'reset' that management openly warns 'has caused recent volatility in certain channels and geographies.' After a brutal top-line collapse from $704M (FY2022) to $423M (FY2024), FY2025 revenue was essentially flat at $423M (+0.1%) — the first sign the bleeding has stopped. Underneath, the mix is improving: professional +5.5% and DTC +3.1%, offset by specialty retail -8.3%. Gross margin even ticked up to 69.4% as obsolescence write-offs fell ($5.6M vs $7.8M). So the demand side looks like it is troughing rather than imploding.
The problem is profitability. Operating income cratered 89.6% to $6.95M (1.6% margin, down from 15.8%) and the company swung to a $9.25M net loss. The cause is a 33.8% SG&A surge: +$26.7M advertising, +$16.0M legal/professional fees, +$9.3M Purvala acquisition costs, and +$8.9M payroll/realignment. Notably, a chunk of that is arguably non-recurring (the $9.3M deal costs, the legal spike) or a deliberate growth bet (advertising), so underlying earnings power is better than the headline loss — but it is still a long way from the ~24% operating margins of FY2023. The transformation is the entire thesis, and the filing repeatedly flags it 'may result in higher than expected costs, loss of customers, reduced sales volume' and may 'take longer than anticipated, if at all.'
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 6:23 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $598M | $704M | $458M | $423M | $423M |
| Gross profit | $474M | $520M | $319M | $292M | $294M |
| Operating income | $334M | $364M | $108M | $66.9M | $6.95M |
| Net income | $221M | $244M | $61.6M | $19.5M | -$9.25M |
| Diluted EPS | $0.32 | $0.35 | $0.09 | $0.03 | -$0.01 |
| Net margin | 36.9% | 34.7% | 13.4% | 4.6% | -2.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
DEF 14A proxy: routine governance, board and executive-comp voting items
DEF 14A proxy: routine governance, board and executive-comp voting items
Q1 FY26 10-Q: results amid intl distribution reset and soft specialty retail
Q1 FY26 10-Q: results amid intl distribution reset and soft specialty retail
10-K/A amendment, typically Part III governance detail; no new financials
Entered a material agreement (1.01) plus Reg FD disclosure; terms drive the read
FY2025 10-K: $9.3M net loss, SG&A +34%, operating margin collapsed to 1.6%
FY2025 10-K: $9.3M net loss, SG&A +34%, operating margin collapsed to 1.6%
Q3 2025 10-Q; revenue flat, transformation costs pressuring profitability
Sources: SEC EDGAR (CIK 0001868726, latest 10-Q filed 2026-05-11) · EODHD · Proprietary analysis · as of 6/30/2026, 10:23:02 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 2 sales
| 2026-05-26 | FOX TRISHA L Chief People Officer | Sell | 16.3K @ $2.04 | $33.3K |
| 2026-04-14 | Duffy John C General Counsel | Sell | 11.5K @ $2.02 | $23.2K |
| 2026-03-13 | Baldwin Amanda Chief Executive Officer | Sell | 452K @ $1.17 | $529K |
| 2026-03-12 | FOX TRISHA L Chief People Officer | Sell | 25.4K @ $1.26 | $32.0K |
| 2026-03-12 | Duffy John C General Counsel | Sell | 35.0K @ $1.26 | $44.1K |
| 2026-03-12 | DUNLEAVY CATHERINE COO and CFO | Sell | 93.8K @ $1.26 | $118K |
| 2026-03-10 | FOX TRISHA L Chief People Officer | Award | 385K | |
| 2026-03-10 | Duffy John C General Counsel | Award | 385K | |
| 2026-03-09 | FOX TRISHA L Chief People Officer | Sell | 26.4K @ $1.26 | $33.3K |
| 2026-03-09 | Duffy John C General Counsel | Sell | 34.8K @ $1.26 | $43.9K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.